E-Cadherin is a diagnostic biomarker in the progression of oral epithelial dysplasia to squamous cell carcinoma
Open Access
- 14 March 2025
- journal article
- Published by Elsevier in Journal of Oral Biology and Craniofacial Research
- Vol. 15 (3) , 508-514
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Oral epithelial dysplasia: Causes, quantification, prognosis, and management challengesPeriodontology 2000, 2019
- Cadherins in collective cell migration of mesenchymal cellsCurrent Opinion in Cell Biology, 2012
- Epithelial to mesenchymal transition (EMT) biomarkers – E-cadherin, beta-catenin, APC and Vimentin – in oral squamous cell carcinogenesis and transformationOral Oncology, 2012
- The cell-cell adhesion molecule E-cadherinCellular and Molecular Life Sciences, 2008
- Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvementJournal of Oral Pathology & Medicine, 2008
- Differential expression of E‐cadherin in metastatic lesionscomparing to primary oral squamous cell carcinomaJournal of Oral Pathology & Medicine, 2006
- Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinomaOral Oncology, 2006
- Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavityThe Journal of Pathology, 1998
- Expression of cadherins and catenins in oral epithelial dysplasia and squamous cell carcinomaJournal of Oral Pathology & Medicine, 1998
- Immunohistochemical study of desmosomes in oral squamous cell carcinoma: correlation with cytokeratin and E-cadherin staining, and with tumour behaviourThe Journal of Pathology, 1998